Kolon Life Science to ship first supply of ‘Invossa’ to Hong Kong and Macao

Published: 2018-08-27 09:32:00
Updated: 2018-08-27 17:37:26

Kolon Life Science(CEO Woo-Seok Lee) announced to ship the first supply of the knee arthritis gene therapy ‘INVOSSA-K’ to Hong Kong and Macao.

This shipment is the first supply to Hong Kong and Macao after the agreement with Zhongji 1 International Medical Group on 20 June. The company agreed to...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.